Yongxin Zhang, Ying Wang
Multiple Myeloma (MM), a prevalent hematological cancer, remains a challenge due to its intricate nature and variable outcomes. Cytogenetics, the study of chromosome structure and function, has emerged as a critical tool in uncovering the genetic landscape driving MM. This article explores the transformative impact of cytogenetics on MM diagnosis, prognosis, and treatment.